PTCT
March 28 (Reuters) - PTC Therapeutics said on Friday the European Commission will remove its inherited progressive muscle-wasting disorder from the region after an advisory panel reaffirmed a negative opinion of the drug in January. (Reporting by Christy Santhosh in Bengaluru; Editing by Shailesh Kuber)